What additional information must be indicated on a label when a drug is added to a parenteral admixture?

When a drug is added to a parenteral admixture, it is essential to indicate the date of addition on the label. Including this information helps ensure proper tracking of the admixture and aids in maintaining the safety and efficacy of the compounded formulation. The date is particularly important for stability and expiration considerations, as certain drug components have specific shelf lives once added to a mixture. This time-stamping allows healthcare professionals to monitor the integrity of the admixture and make informed decisions regarding its use.

Details such as the prescriber’s name, manufacturer information, and patient history, while important in their own rights for various medication management processes, do not specifically relate to the requirements of labeling parenteral admixtures. The emphasis on the date provides critical context for safe administration and timing of the administration of that admixture to the patient. Ensuring that the date is noted helps practitioners adhere to best practices and regulatory compliance concerning compounded medications.